BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katanoda K, Hori M, Saito E, Shibata A, Ito Y, Minami T, Ikeda S, Suzuki T, Matsuda T. Updated Trends in Cancer in Japan: Incidence in 1985-2015 and Mortality in 1958-2018-A Sign of Decrease in Cancer Incidence. J Epidemiol 2021;31:426-50. [PMID: 33551387 DOI: 10.2188/jea.JE20200416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yashima K, Shabana M, Kurumi H, Kawaguchi K, Isomoto H. Gastric Cancer Screening in Japan: A Narrative Review. J Clin Med 2022;11:4337. [PMID: 35893424 DOI: 10.3390/jcm11154337] [Reference Citation Analysis]
2 Shrestha RM, Mizoue T, Sawada N, Matsuo K, Wada K, Tanaka K, Lin Y, Sugawara Y, Takimoto H, Kimura T, Ito H, Kitamura T, Sakata R, Tanaka S, Inoue M; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Adult height in relation to the risk of colorectal cancer among the Japanese population: an evaluation based on systematic review and meta-analysis. Jpn J Clin Oncol 2021:hyab203. [PMID: 34969070 DOI: 10.1093/jjco/hyab203] [Reference Citation Analysis]
3 Mo X, Moriwaki K, Morimoto K, Shimozuma K. Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan. Clin Drug Investig 2022;42:599-609. [PMID: 35675029 DOI: 10.1007/s40261-022-01168-0] [Reference Citation Analysis]
4 Kamo KI, Fukui K, Ito Y, Nakayama T, Katanoda K. How much can screening reduce colorectal cancer mortality in Japan? Scenario-based estimation by microsimulation. Jpn J Clin Oncol 2021:hyab195. [PMID: 34897471 DOI: 10.1093/jjco/hyab195] [Reference Citation Analysis]
5 Watanabe Y, Katagiri R, Goto A, Shimazu T, Yamaji T, Sawada N, Iwasaki M, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group. Dietary glycemic index, glycemic load, and endometrial cancer risk: The Japan Public Health Center-based Prospective Study. Cancer Sci 2021;112:3682-90. [PMID: 34053169 DOI: 10.1111/cas.14997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Yang X, Chen H, Sang S, Chen H, Li L, Yang X. Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA. Front Public Health 2022;10:862165. [DOI: 10.3389/fpubh.2022.862165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Endo S, Terazawa T, Goto M, Tanaka R, Kato T, Fujitani K, Kawakami H, Sakai D, Kurokawa Y, Tsujinaka T, Shimokawa T, Satoh T. Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09890-w] [Reference Citation Analysis]
8 Hayashi T, Miyamoto T, Nagai N, Kawabata A. Development of diabetes mellitus following hormone therapy in prostate cancer patients is associated with early progression to castration resistance. Sci Rep 2021;11:17157. [PMID: 34433857 DOI: 10.1038/s41598-021-96584-1] [Reference Citation Analysis]
9 Saito E, Yano T, Hori M, Yoneoka D, Matsuda T, Chen Y, Katanoda K. Is young‐onset esophageal adenocarcinoma increasing in Japan? An analysis of population‐based cancer registries. Cancer Medicine. [DOI: 10.1002/cam4.4528] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ohmura SI, Tamechika SY, Miyamoto T, Kunieda K, Naniwa T. Impact of dysphagia and its severity on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathies other than inclusion body myositis. Int J Rheum Dis 2022. [PMID: 35678075 DOI: 10.1111/1756-185X.14365] [Reference Citation Analysis]
11 Kawai S, Wang C, Lin Y, Sasakabe T, Okuda M, Kikuchi S. Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study. Int J Cancer 2022;150:18-27. [PMID: 34449868 DOI: 10.1002/ijc.33773] [Reference Citation Analysis]
12 Kawakita D, Oze I, Iwasaki S, Matsuda T, Matsuo K, Ito H. Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan. Cancer Medicine. [DOI: 10.1002/cam4.4539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, Kantilal K, Katanoda K, Kenis C, Lu-Yao G, Matsuda T, Navarrete E, Nikita N, Puts M, Strohschein FJ, Morris EJA. International trends in cancer incidence in middle-aged and older adults in 44 countries. J Geriatr Oncol 2021:S1879-4068(21)00257-5. [PMID: 34866023 DOI: 10.1016/j.jgo.2021.11.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Kuroyama Y, Geshi E. Preoperative Physical Inactivity Affects the Postoperative Course of Surgical Patients with Lung Cancer. Phys Ther Res 2021;24:256-63. [PMID: 35036260 DOI: 10.1298/ptr.E10127] [Reference Citation Analysis]
15 Katanoda K, Ito Y, Sobue T. International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers. Jpn J Clin Oncol 2021;51:1680-6. [PMID: 34467393 DOI: 10.1093/jjco/hyab139] [Reference Citation Analysis]